
ProofPilot’s Lauren Briggs talks on why sponsors and CROs fail at tech rollouts by skipping change management, and pushes for the industry to judge trial technology by real workflow impact rather than feature checklists.
Rare disease clinical research is complex. By shifting perspective and focusing on the patient experience throughout clinical trials, trial sponsors can learn about the unique barriers faced by patients and their loved ones, improve participation rates, and optimize the impact and outcomes of such studies.






